ClinicalTrials.Veeva

Menu

Influence of Improved Formula on Fatty Acids and Mineral Metabolism in Infants

B

Beingmate Baby & Child Food

Status

Unknown

Conditions

Healthy

Treatments

Other: β-Palmitate Content
Other: Placebo
Other: β-Palmitate Content Naturely in Human Milk

Study type

Interventional

Funder types

Other

Identifiers

NCT02587702
RDM2012002

Details and patient eligibility

About

The purpose of this study is to determine whether different content of β-palmitate will cause significant differences on Fatty Acids and Mineral Metabolism in Infants

Enrollment

90 estimated patients

Sex

All

Ages

Under 7 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy full term infants

Exclusion criteria

  • experienced congenital or chromosomal disorders
  • neonatal morbidities, or metabolic illness

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 3 patient groups, including a placebo group

Improved Infant Formula Group
Experimental group
Description:
Containing β-Palmitate Content
Treatment:
Other: β-Palmitate Content
General Infant Formula Group
Placebo Comparator group
Description:
Excluding β-Palmitate Content
Treatment:
Other: Placebo
Human Milk Group
Active Comparator group
Description:
Containing β-Palmitate Content Naturely in Human Milk
Treatment:
Other: β-Palmitate Content Naturely in Human Milk

Trial contacts and locations

1

Loading...

Central trial contact

Fei Bei, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems